News

The order includes purchase of PrioClear, a prion capture resin incorporated into Octapharma’s manufacturing process for its solvent/detergent treated plasma product, Octaplas LG. The resumption of PrioClear supply

The vaccine, ID93/GLA-SE contains fusion protein of four antigens and a synthetic adjuvant formulation, which together enable T-cells to induce effective immunity and protect against TB ID93/GLA-SE will

The company inked a deal with Institute of Pharmacology and Toxicology of the Academy of Military Medical Sciences in China to complete final toxicology tests for AGX-1009, a

The vaccine targets and eliminates the alpha-synuclein protein, whose clumping is a sign of PD. PD01 vaccine has shown to stimulate the immune system to release antibodies that

The patent specifically covers the company’s RX-8243 which is currently in pre-clinical development. According to the company, RX-8243 has demonstrated potent anti-tumor properties in many cancer cell lines,

Alpha-2b incorporates the company’s Biphasix drug delivery technology and provides a better means of delivering interferon-alpha-2b therapeutically to human papillomavirus (HPV) infected tissues. FDA will take 30 days

Under the agreement, which spans over 18 months, the companies will analyse the genomes of patients to search for sequence variants to gain further insights into drug targets.

The Ramsell Care Continuum is an integrated solution developed specifically for an ADAP program to address the needs of HIV/AIDS patients. The Ramsell Care Continuum features a software

GMI-1070 is a pan-selectin antagonist currently in Phase 2 development for the treatment of vaso-occlusive crisis associated with sickle cell disease. GMI-1070, which is believed to inhibit selectin